ArticleCellular oncology (Dordrecht, Netherlands)2025
Correction to: Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
Ioannis Pozios et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.